Clinical Trials
2 trialsNCT01103375 2018-08-01
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Wake Forest University Health Sciences
Phase 1 Terminated
NCT00003564 2012-02-22
Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
M.D. Anderson Cancer Center
Phase 3 Withdrawn